Prodigy Care Services

10/17/2026

Today’s breakthrough could become tomorrow’s treatment option.

Every new FDA approval adds another possibility to an evolving pharmaceutical landscape.

Some therapies target rare conditions. Others introduce novel mechanisms of action or new approaches to complex diseases.

Not every approval will immediately affect workers’ compensation. But understanding what’s entering the market helps payers, clinicians, and claims professionals prepare for what comes next.

In our Q3 2026 FDA Pipeline Report, Prodigy examines newly approved therapies, their indications, mechanisms of action, and key clinical considerations.

Because staying ahead of pharmacy trends starts with understanding the science behind them.

New therapies. Emerging science. Better-informed decisions.

Read the report → https://www.prodigycareservices.com/blog/https/wwwcanvacom/design/dahp9yvzn3m/bgbassrcrvmxkdwpkbsk2w/view-yxhrn

Prodigy continues to monitor novel drug approvals from the U.S. Food and Drug Administration (FDA) to help stakeholders stay informed of emerging therapies entering the market. This Q3 2026 report highlights all novel drug approvals during the quarter and provides an overview of their indications,

10/13/2026

50 years of workers’ comp conversations. And we can hardly wait to celebrate.

We’re proud to join SCWCEA in honoring the past and shaping the future—one built on greater transparency, stronger accountability, and better outcomes.

See you at SCWCEA.
https://www.prodigycareservices.com/connect

10/09/2026

A workplace exposure today could become a specialty pharmacy claim tomorrow. Biologics are expanding beyond severe asthma into COPD.

More treatment options.
More clinical complexity.
More pressure on pharmacy spend.

The question isn't just what these drugs cost. It's who really needs them.

Read more: How specialty respiratory drugs are changing workers' comp. https://www.prodigycareservices.com/blog/5-common-mental-health-medications-used-for-conditions-used-in-workers-comp-w4ds3-yzadd

10/05/2026

Five years in, and this evening continues to be one of our favorite traditions.

Thank you to everyone who joined us for Cocktails by Prodigy in Las Vegas. Great conversations, new connections, old friends—and a room full of people who care deeply about making workers’ comp better.

We’re grateful for this community and for the clients, partners, and friends who continue to believe in what we’re building.

Until next year. 🍸

09/22/2026

National Work Comp is here. Let’s talk about what’s next.
Bring us your toughest questions about PBM, specialty, and post-acute care.

The Prodigy team will be in Las Vegas and ready for the conversations that move workers’ comp forward.

Let’s connect: prodigycareservices.com/connect

09/19/2026

Leadership sets the standard. The work proves it.
Outcomes tell the story.

Congratulations to Dr. Tyrone Spears and the City of Los Angeles for building a better system for the people they serve.

https://riskandinsurance.com/2026-theo-award-winner-city-of-los-angeles/

09/15/2026

More reviews. More interventions. More programs. More touchpoints.
The real question is: does the claim actually need them?

We believe good clinical stewardship starts with understanding the patient and the claim—then applying the right resources at the right time.

Sometimes that means intervening. Sometimes it means monitoring. And sometimes the right decision is to leave good care alone.

Because the value isn’t in having more tools.
It’s knowing which tool to use—and when.

→ prodigycareservices.com/act

09/10/2026

The opioid playbook has changed.
Shorter prescriptions.
More oversight.
Better visibility through PDMPs.

The goal isn’t eliminating opioids. It’s making sure the right patient gets the right therapy, for the right amount of time.

Read more: How evolving opioid policies are reshaping pain management and recovery in workers’ compensation.

https://www.prodigycareservices.com/blog/5-common-mental-health-medications-used-for-conditions-used-in-workers-comp-w4ds3

09/07/2026

Great organizations are built by great people. This Labor Day, we’re especially grateful for the Prodigy team—the people who show up every day for our clients, our patients, and each other.

Proud of this team. Thankful for every one of them.

09/05/2026

Pulmonary fibrosis can progress for years.
Treatment can cost even longer.

The treatment landscape is changing.
The economics of antifibrotic therapy are beginning to change.

Read more: Why Ofev®, Esbriet®, and new generics should be on your radar.

https://www.prodigycareservices.com/blog/whats-lurking-in-the-dust-z4rl3